We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Novartis AG | NYSE:NVS | NYSE | Depository Receipt |
| Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.68 | 0.70% | 98.18 | 443 | 10:31:51 |
From May 2019 to May 2024
LONDON-- Pharmaceutical services group Ergomed PLC (ERGO.LN) Thursday announced the appointment of Andrew Mackie, who has held senior research and development roles at pharma companies including Novartis AG (NVS) and Sanofi (SNY), as Chief Business Officer and executive director, effective from 1 July 2015.
Shares at 0717 GMT, unchanged at 180 pence valuing the company at GBP51.6 million.
-Write to Rory Gallivan at rory.gallivan@wsj.com; Twitter: @RoryGallivan
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Novartis Chart |
1 Month Novartis Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
